Related Experiment Videos
Early-onset, rapidly progressive familial tauopathy with R406W mutation
1Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, University of Tokyo, Japan.
Abstract:
An early-onset and rapidly progressive familial tauopathy with R406W mutation is described. The patient was a 47-year-old man who first presented with psychiatric symptoms followed by overt dementia at age 52 and died 1 year later. Postmortem study revealed tangle-associated neuronal degeneration, accentuated in the medial temporal lobe. R406W mutation was determined by sequence analysis and immunocytochemically with anti-mutant tau antibody.
Insights
This study describes a rare familial tauopathy with a specific R406W mutation, presenting early and progressing rapidly. Postmortem analysis confirmed neurodegeneration, highlighting the mutation
Area of Science:
- Neurodegenerative diseases
- Genetics of neurological disorders
- Tauopathies
Background:
- Familial tauopathies are rare genetic disorders characterized by the accumulation of tau protein aggregates in the brain.
- The R406W mutation in the tau gene is associated with certain forms of frontotemporal dementia and Alzheimer's disease.
Observation:
- A 47-year-old man presented with early-onset psychiatric symptoms, followed by dementia at age 52.
- The patient experienced a rapidly progressive disease course, succumbing to the illness one year after dementia onset.
- Postmortem examination revealed significant tangle-associated neuronal degeneration, particularly in the medial temporal lobe.
Findings:
- Sequence analysis confirmed the presence of the R406W mutation in the tau gene.
- Immunocytochemical analysis using an anti-mutant tau antibody further validated the mutation's presence and its association with tau pathology.
Implications:
- This case highlights the R406W mutation as a cause of early-onset, rapidly progressive familial tauopathy.
- Understanding the specific pathological features associated with this mutation can aid in diagnosis and the development of targeted therapies.
- Further research into familial tauopathies can elucidate the complex mechanisms underlying tau protein aggregation and neurodegeneration.